---
title: "Medtronic PLC Stock Outperforms Competitors Despite Losses On The Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296534101.md"
description: "Medtronic PLC (MDT) shares fell 1.94% to $92.30 on Thursday, snapping a two-day winning streak amid a broader market decline. Despite the drop, Medtronic outperformed competitors like Johnson & Johnson and Abbott Laboratories. The stock remains 13.19% below its 52-week high of $106.33. Trading volume was lower than the 50-day average."
datetime: "2026-08-20T20:38:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296534101.md)
  - [en](https://longbridge.com/en/news/296534101.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296534101.md)
generator: "portal-rs"
---

# Medtronic PLC Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Medtronic PLC (MDT) shed 1.94% to $92.30 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.87% to 7,641.16 and Dow Jones Industrial Average falling 1.32% to 52,759.21.

The stock's fall snapped a two-day winning streak.

Medtronic PLC closed 13.19% below its 52-week high of $106.33, which the company achieved on November 26th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 2.21% to $267.37, Danaher Corp. (DHR) rose 2.09% to $215.91, and Abbott Laboratories (ABT) fell 0.25% to $114.14.

Trading volume (6.0 M) remained 2.0 million below its 50-day average volume of 8.1 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-20-26 1638ET

### Related Stocks

- [MDT.US](https://longbridge.com/en/quote/MDT.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Orchestra BioMed highlights $500 million-plus annual royalty potential from Medtronic-partnered AVIM pacemaker therapy](https://longbridge.com/en/news/298326982.md)
- [Medtronic Analysts Raise Their Forecasts After Upbeat Q1 Earnings](https://longbridge.com/en/news/297780375.md)
- [Medtronic’s Stars Are Aligning for a Price Recovery](https://longbridge.com/en/news/297677128.md)
- [22:45 ETCornerstone Robotics ogłasza strategiczne partnerstwo z Medtronic mające na celu zwiększenie dostępu do chirurgii robotycznej na świecie](https://longbridge.com/en/news/297724147.md)
- [Analyst Reiterates Buy on Medtronic as CAS Expansion and Strategic Robotics Partnerships Support Long-Term Upside](https://longbridge.com/en/news/297687155.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**